PwC has reportedly been appointed to review spiralling costs at the new Children’s hospital

Minister for Finance Paschal Donohoe met senior executives from Apple while on a trade mission to Silicon Valley last week, according to the Sunday Bu(...)

Seroba managing partner Peter Sandys. The Irish venture capital firm has invested further in Endotronix

Irish venture capital firm Seroba Life Sciences has participated in a new $45 million (€39 million) financing round for Endotronix, a US medtech compa(...)

Seroba managing partner Peter Sandys

Irish venture capital firm Seroba Life Sciences stands to make a return of up to €100 million following the recent sale of a company it invested in ju(...)

Discovering drugs: “Blue skies research is essential. That is where the biggest value is.  You have to fund research here because you never know: we might crack it.”

For decades now, successive governments have courted big pharma and encouraged them to set up in Ireland and manufacture their drugs. This has created(...)

Prof Luke O’Neill: “I won’t be quitting the immune system any time soon.” Photograph: Nick Bradshaw

Prof Luke O’Neill is happy. This is not unusual: the biochemistry professor is known for his ebullience. But there’s an extra dimension to the good h(...)

Trinity College Dublin. Photograph: Bryan O’Brien

Trinity College Dublin and UCD have put their rivalry aside to collaborate on a new €60 million investment fund for high-potential start-ups. Speci(...)

A globally recognised centre of excellence in medical technology, or medtech, Ireland is home to more than 300 companies, employing 25,000 people. (...)

Opsona Therapeutics, a biopharma company spun out of Trinity College (above), is developing drugs designed to block a protein  in the body that works to reject foreign organisms. Photograph: Dara Mac Donaill

Opsona Therapeutics, a biopharma company spun out of Trinity College, has embarked on a series of trials to see if its leading therapy could prove ef(...)

Irish companies raised €285 million from venture capital investors last year, according to new data from the Irish Venture Capital As(...)

Irish biopharma company Opsona Therapeutics last week announced a new round of investment, to the tune of €33 million. Their goal? To dampen th(...)